Naivex (Dolutegravir) is an FDA-approved drug

Naivex (Dolutegravir) is an FDA-approved drug. it is used for the treatment and the management of HIV infection. Naivex is an integrase inhibitor. By blocking integrase, integrase inhibitors prevent HIV from multiplying and

can reduce the amount of HIV in the body.

Mechanism of action:

Naivex(Dolutegravir) is an HIV-1 antiviral agent. It inhibits HIV integrase by binding to the active site and blocking the strand transfer step to retroviral DNA integration. This is an essential step of the HIV replication cycle and will result in an inhibition of viral activity.